These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10385751)

  • 1. Pulmonary embolism thrombolysis: Do we need another agent?
    Goldhaber SZ
    Am Heart J; 1999 Jul; 138(1 Pt 1):1-2. PubMed ID: 10385751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS
    Klin Med (Mosk); 2004; 82(10):4-8. PubMed ID: 15584590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolysis in pulmonary embolism].
    Thabut G; Jebrak G
    Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 5. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction.
    Meneveau N; Schiele F; Vuillemenot A; Valette B; Grollier G; Bernard Y; Bassand JP
    Eur Heart J; 1997 Jul; 18(7):1141-8. PubMed ID: 9243149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of massive pulmonary embolism with prolonged catheter-directed thrombolysis.
    Kelly P; Carroll N; Grant C; Barrett C; Kocka V
    Heart Vessels; 2006 Mar; 21(2):124-6. PubMed ID: 16550314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy for venous thromboembolism.
    Hyers TM
    Chest; 1993 May; 103(5):1636. PubMed ID: 8486070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombolytic therapy in pulmonary embolism. Indications and therapeutic strategies].
    Niedermeyer J; Meissner E; Fabel H
    Z Gesamte Inn Med; 1993; 48(6-7):332-43. PubMed ID: 8333230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy for submassive pulmonary embolism.
    Lankeit M; Konstantinides S
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):379-89. PubMed ID: 22959553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
    Lu HR; Lijnen HR; Stassen JM; Collen D
    Blood; 1991 Jul; 78(1):125-31. PubMed ID: 1906351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis.
    Schneider J; Friderichs E; Günzler WA; Flohé L
    Thromb Res; 1989 Oct; 56(1):59-65. PubMed ID: 2512686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of recombinant thrombolytics: Current status and future directions.
    Adivitiya ; Khasa YP
    Bioengineered; 2017 Jul; 8(4):331-358. PubMed ID: 27696935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
    Enevoldsen MT; Rørdam P; Schroeder TV
    Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up.
    Meneveau N; Schiele F; Metz D; Valette B; Attali P; Vuillemenot A; Grollier G; Elaerts J; Mossard JM; Viel JF; Bassand JP
    J Am Coll Cardiol; 1998 Apr; 31(5):1057-63. PubMed ID: 9562007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute myocardial infarction: thrombolytic therapy in ambulance?].
    Martens F
    Internist (Berl); 2001 May; 42(5):682-5. PubMed ID: 11400575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.